$BGMD Headlines BG Medicine Inc. falls 10% in premarket

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$BGMD Headlines

BG Medicine Inc. falls 10% in premarket 8:58 a.m. Jan. 25, 2013 - Steve Gelsi
BG Medicine up 11% in premarket 8:57 a.m. Jan. 3, 2013 - Steve Gelsi
BG Medicine up by 16% in premarket 9:49 a.m. Dec. 14, 2012 - Steve Gelsi
BG Medicine rises 9% in premarket 10:17 a.m. Dec. 12, 2012 - Steve Gelsi
BG Medicine names BioMerieux exec as CEO 10:12 a.m. Jan. 9, 2012 - Steve Gelsi
BG Medicine names Eric Bouvier as CEO 9:38 a.m. Jan. 9, 2012 - Steve Gelsi
IPO scorecard: Pacira, Epocrates up in aftermarket 2:56 p.m. April 27, 2011 - MarketWatch.com
IPO Scorecard: Update on selected stock offerings 2:31 p.m. April 26, 2011 - MarketWatch.com

10-K: BG MEDICINE, INC. 5:05 p.m. March 27, 2014 - Edgar Online - (EDG = 10Q, 10K)
Insider Buying Is On The Rise In These 4 Rallying Stocks 6:16 p.m. March 20, 2014 - TheStreet.com
Why BG Medicine (BGMD) Hit a One-Year High Today (Update) 4:41 p.m. March 20, 2014 - TheStreet.com
BG Medicine's CEO Discusses Q4 2013 Results - Earnings Call Transcript 1:31 p.m. March 20, 2014 - Seeking Alpha
BG Medicine, Inc. Discusses Q4 2013 Results (Webcast) 8:25 a.m. March 20, 2014 - Seeking Alpha
BG Medicine up big in today's trading 1:51 p.m. March 18, 2014 - Seeking Alpha
BG Medicine meets Nasdaq requirements, shares soar 10:07 a.m. March 12, 2014 - Seeking Alpha
3 Life Science Stocks to Sell Now 3:15 a.m. Feb. 20, 2014 - InvestorPlace.com
3 Life Science Stocks to Sell Now 2:30 p.m. Jan. 30, 2014 - InvestorPlace.com
BG Medicine +24%, says clinical study shows performance of automated VIDAS 3:29 p.m. Jan. 28, 2014 - Seeking Alpha
HWAY and SulAmerica Join Forces, Shares Fall - Analyst Blog 7:30 p.m. Dec. 9, 2013 - Zacks.com
Omnicare Raises Dividend, Approves Share Repurchase - Analyst Blog 4:00 p.m. Dec. 9, 2013 - Zacks.com
Intrexon Corporation (XON) in Focus: Stock Jumps 8.6% - Tale of the Tape 10:25 a.m. Nov. 18, 2013 - Zacks.com
BG Medicine's CEO Discusses Q3 2013 Results - Earnings Call Transcript 12:03 a.m. Nov. 7, 2013 - Seeking Alpha
Healthways Partnership Expands But Stock Down - Analyst Blog 2:50 p.m. Oct. 7, 2013 - Zacks.com
CareFirst Invests in Healthways Partnership - Analyst Blog 2:50 p.m. Oct. 4, 2013 - Zacks.com
NextGxDx and athenahealth Join Forces - Analyst Blog 6:10 p.m. Oct. 1, 2013 - Zacks.com
BG Medicine Says Prelim. Decision by CMS on Galectin-3 National limitation $30.24 7:33 a.m. Sept. 30, 2013 - benzinga.com
BG Medicine - Just Be Patient 4:02 a.m. Aug. 15, 2013 - Seeking Alpha
10-Q: BG MEDICINE, INC. 4:10 p.m. Aug. 9, 2013 - Edgar Online - (EDG = 10Q, 10K)


Hewlett-Packard to Enter the 3d Printing Market; BG Medicine Announces Positive Data from Clinical Research Trials 12:26 a.m. March 26, 2014 - ACCESSWIRE
Publication Reports Clinical Utility of BGM Galectin-3(R) Test for Prediction of Near-Term Rehospitalization in Patients With Heart Failure 8:31 a.m. March 25, 2014 - GlobeNewswire
Lawsuits, Clinical Studies, Financial Results, and Stock Movements - Analyst Notes on Idenix, BG Medicine, Progenics, Omeros, and Opexa 8:00 a.m. March 21, 2014 - PR Newswire - PRF
BG Medicine Announces Issuance of Patent Covering Galectin-3 Testing for Cardiac Resynchronization Therapy 8:15 a.m. March 20, 2014 - GlobeNewswire
BG Medicine Reports 2013 Fourth Quarter and Year End Financial Results 7:50 a.m. March 20, 2014 - GlobeNewswire
Coverage of Top Gainers -- Research on Synta Pharma, BG Medicine, Abraxas Petroleum, and xG Technology 8:25 a.m. March 19, 2014 - PR Newswire - PRF
BG Medicine Announces Fiscal Year 2013 Financial Results Release Date and Conference Call Information 4:48 p.m. March 13, 2014 - GlobeNewswire
BG Medicine Welcomes La Jolla Pharmaceutical Company's Announcement of Positive Top-Line Results of Phase 2 Clinical Trial of Novel Pharmaceutical Compound Targeting Galectin-3 in Chronic Kidney Disease 8:46 a.m. March 12, 2014 - GlobeNewswire
BG Medicine Compliant With NASDAQ Listing Requirements 6:02 p.m. March 11, 2014 - GlobeNewswire
BG Medicine Welcomes Inclusion of Galectin-3 in 2014 Indian Consensus Document on Cardiac Biomarkers 8:30 a.m. March 10, 2014 - GlobeNewswire
Can This Simple Test Predict Your Chances of Dying? If You Have Coronary Artery Disease, The Answer Is Yes, Say A Group of Renowned Scientists 10:00 a.m. Feb. 5, 2014 - BusinessWire - BZX
Heart Failure Study Proves Serial Testing of ST2 Can Help Improve Patient Care And Reduce Cardiovascular Events 9:59 a.m. Feb. 3, 2014 - BusinessWire - BZX
Automated VIDAS(R) Galectin-3 Assay Validated in Published Clinical Research Study 9:31 a.m. Jan. 28, 2014 - GlobeNewswire
BG Medicine to Transfer to the NASDAQ Capital Market; Obtains Requested NASDAQ Extension 9:30 a.m. Jan. 27, 2014 - GlobeNewswire
Clinical Trial Results, Partnerships, and Reimbursement Rates - Research Report on Celldex, Centene, Enanta, Novartis, and BG Medicine 9:00 a.m. Dec. 13, 2013 - PR Newswire
BG Medicine Welcomes Final Determination by CMS of 2014 Reimbursement for BGM Galectin-3(R) Test 9:30 a.m. Dec. 10, 2013 - GlobeNewswire
Independent Multicenter Trial Demonstrates Utility of BGM Galectin-3(R) Test for Accurately Classifying Risk of Unplanned Hospital Readmissions and Adverse Outcomes in Patients With Heart Failure 9:30 a.m. Nov. 19, 2013 - GlobeNewswire
BG Medicine, Inc. Appoints Stephen P. Hall as Chief Financial Officer 9:30 a.m. Nov. 14, 2013 - GlobeNewswire
AXAS, POZN, ATRS and BGMD added to NASDAQ Active Stock Watch List at EPR 10:29 a.m. Nov. 6, 2013 - ACCESSWIRE
BG Medicine Reports 2013 Third Quarter Financial Results 8:35 a.m. Nov. 6, 2013 - GlobeNewswire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Leica Oskar Barnack Awards Spotlight Global Talent

Updated Category News Views 1

Winners Redefine Photography's Boundaries in 2026 Photographers are like modern-day storytellers, freezing moments in time and weaving visual narratives that provoke thought—or at least that's what the folks behind the Leica Oskar Barnack Award (LOBA) seem to believe. This year's ceremony upped the ante, not just handing out glittering prizes and shiny cameras, but...

Continue Reading
Ajman Tourism Department Hits Internal Audit Milestone

Updated Category News Views 4

A Nod to Standards in Ajman's Tourism Department Folks, it's not every day you see a government department get this kind of spotlight in the internal audit arena, yet here we are. The Ajman Department of Tourism, Culture and Media has snagged Full Conformance with Internal Audit Quality Standards. That’s not just some random feather in their cap but a signal flare in...

Continue Reading
Full Sail University Bags Billboard Music School Honor

Updated Category News Views 8

Full Sail Scores a Billboard Nod — What's the Big Deal? Alright, Full Sail University just snagged a spot on Billboard Magazine's 2026 Top Music Business Schools list. That's no small fry, folks. This Florida institution has been carving out a niche in the music business education scene with a hands-on learning approach that hits the nail right on the head. The Recipe...

Continue Reading
Lupin Secures FDA Nod for Key Injectable Drug

Updated Category News Views 4

Lupin's FDA Approval: A Strategic Play in Pharmaceuticals Ah, the thrill of a new approval! Lupin Limited has landed U.S. FDA approval for their Phytonadione Injectable Emulsion, marking a significant stride into the lucrative realm of vitamin K treatments. This approval isn't just a feather in Lupin's cap—it's a calculated move to corner a piece of the estimated $52.3...

Continue Reading
Teamsters Secure Landmark Deal for SF Parking Workers

Updated Category News Views 5

Major Win for San Francisco's Parking Professionals Parking lots and garages across San Francisco might not be the first places you’d look for labor triumphs, but that’s exactly what almost 1,000 members of Teamsters Local 665 have achieved. Under a newly ratified four-year master contract, these parking pros snagged one of the richest deals the industry has seen. A...

Continue Reading
Ingram Mercantile's Aviation Push: SCORE or Sink?

Updated Category News Views 0

Unpacking Neobanx's Strategic Play Straight off the tarmac, Neobanx launches Ingram Mercantile, placing their bets on the aviation sector with none other than Eli Stepp at the helm. This ain't just another day in the sky for those in the know; it's part of a gutsy bid to inject some high-octane intelligence into the world of retail. I mean, have you seen the landscape...

Continue Reading
Mexico's Beaches Shine in 2026 Best America Rankings

Updated Category News Views 5

Mexican Shores Turning Heads in 2026 This isn’t just another wave in tourism news; it’s a tidal shift towards Mexico’s sizzling beaches claiming some prime spots on the global travel stage. If you’ve got an eye for tourism dynamics, listen up because Mexico’s sun-soaked shores just snagged six spots among the top 20 beaches in the Americas, according to the...

Continue Reading
Raken Debuts Change Orders: A Game-Changer for Builds

Updated Category News Views 4

Construction Gets a Streamlined Boost with Raken's New Tool In construction, chaos often partners seamlessly with progress. But Raken is stepping in to shake things up a bit. This isn’t just another run-of-the-mill software update; this is Raken flexing its muscles in the construction tech arena. They’ve rolled out Change Orders, enhancing their project management...

Continue Reading
Strategic Move: Chimney Collective Teams with Four Winds

Updated Category News Views 1

A Partnership Fueled by Legacy and Growth In the world of brick, mortar, and flue, a big play just unfolded. Chimney Collective, flexing its investment muscle, has hitched its wagon to Four Winds Chimney, a company that's carved out quite a niche in New York's chimney scene. We're not talking about a corporate takeover here; this is about putting money where growth and...

Continue Reading
Morphe’s Auction Hits High Notes with Fine Jewelry

Updated Category News Views 0

Luxurious Gems Steal the Spotlight When the gavel dropped at Morphy's Fine Jewelry & Watches Auction, it set the stage for a spectacular showcase of opulent treasures. The event, highlighting 632 lots and tallying over $1.8 million in sales, left bidders buzzing in anticipation of their next chance to snag a slice of elegance. Bvlgari's Serpentine Charm In the spotlight...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors' Path to Justice in Reckitt Benckiser Fraud Case

Updated Category News Views 150

Understanding the Reckitt Benckiser Group PLC Securities Fraud Case The Reckitt Benckiser Group PLC (OTC: RBGLY) is currently embroiled in a significant securities fraud issue that has raised alarms among investors. The time frame for potential claims spans from recent months up to a deadline set in the near future, which highlights the urgency for affected parties to act...

Continue Reading
Investors Can Join Class Action Against Hims & Hers Health

Updated Category News Views 111

Opportunity for Investors in Hims & Hers Health If you've significantly lost money from investing in Hims & Hers Health, Inc. (NYSE: HIMS), there is a chance for you to step forward. A notable class action lawsuit is unfolding, inviting investors to take part in holding the company accountable for alleged wrongdoing. This is an important development for shareholders who...

Continue Reading
Mars Acquisition Unit's Journey: Achieving Remarkable Stock Heights

Updated Category News Views 65

Mars Acquisition Unit Stock Reaches New Heights In a clear sign of strong market confidence, Mars Acquisition Unit (MARXU) stock has recently hit a record high, climbing to $12.15. This increase demonstrates the company's impressive performance, highlighting a significant rise in its stock value over the last year. Investors are feeling hopeful thanks to the company’s...

Continue Reading
Middlefield Canadian Income PCC Updates on Net Asset Value Per Share

Updated Category News Views 75

Middlefield Canadian Income PCC Overview Middlefield Canadian Income PCC is an innovative investment vehicle based in Jersey, specifically structured as a protected cell company. This format allows diverse investment strategies while protecting the assets of different cells from each other, creating a safeguarded approach for all investors involved. The company is...

Continue Reading
Investors React to Stride, Inc.'s SEC Complaint and Market Fallout

Updated Category News Views 168

Understanding the Investor Reaction to Stride, Inc. Stride, Inc. (NYSE: LRN), a notable player in the education technology landscape, recently found itself in hot water as a formal complaint emerged. This complaint, filed with the Securities and Exchange Commission (SEC) by a school district, sheds light on serious accusations such as fraud and deceptive practices. The...

Continue Reading